Skip to content

Effect of Osteocare bar on reducing inflammation in patients with knee osteoarthritis

Evaluation of the anti-inflammatory effect of osteocare bar for knee osteoarthritis management: a double-blind, randomized, placebo-controlled trial - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103909
Enrollment
60
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Srushti Sunil Deshpande
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age Group: 35 to 70 years 2.Gender: Both male and female 3.Clinical Diagnosis: ACR criteria for Osteoarthritis of knee joint will be used as diagnostic criteria. 4.Willingness to Participate: Able to understand the study protocol 5.Willing to provide written informed consent and comply with study procedures

Exclusion criteria

Exclusion criteria: 1.Secondary Osteoarthritis (e.g. post-traumatic, post-infectious, or metabolic bone disease) 2.Inflammatory Joint Disorders: Rheumatoid arthritis Gout Psoriatic arthritis or any seronegative arthropathy 3.Systemic Illnesses: Diabetes mellitus Cardiac, hepatic, or renal impairment 4.Recent Joint Procedures: Intra-articular steroid or hyaluronic acid injection within the past 3 months 5.History of knee surgery or arthroscopy within the last 6 months 6.Use of Joint-related Supplements or NSAIDs within 2 weeks before baseline screening 7.Known Allergy or Hypersensitivity to any of the ingredients in Osteocare Bar 8.Pregnant or Lactating Women 9.Participation in another Clinical Trial within the last 3 months 10.Psychiatric or Cognitive Disorders interfering with compliance

Design outcomes

Primary

MeasureTime frame
Reduction in CRP ValueTimepoint: day 0, 15, 30, 60

Secondary

MeasureTime frame
Improved range of motion with Goniometer and pain reductionTimepoint: day 0, 15, 30, 60

Countries

India

Contacts

Public ContactDr Srushti Sunil Deshpande

Parul Institute Of Ayurved And Research

drnareshkore46@gmail.com8275174598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026